Three Key Micro-Cap Holdings —Royce
article 06-02-2026

Three Key Micro-Cap Holdings

Portfolio Manager Jim Stoeffel and Assistant Portfolio Manager Andrew Palen detail the investment thesis for three key holdings in Royce Micro-Cap Fund.

TELL US
WHAT YOU
THINK

We recently looked at the selection process for Royce Micro-Cap Fund, which is enjoying excellent results over the last year (see the performance table below for more details). In this piece, Jim and Andrew offer the investment thesis for three portfolio positions that have earned their long-term confidence.

Apyx Medical (Nasdaq: APYX) provides aesthetic surgical tools with two primary products: Renuvion and the recently launched AYON Body Contouring System. Renuvion is designed to treat the loose skin often associated with liposuction procedures, while the recently launched AYON integrates fat removal and skin tightening. AYON recently received FDA 510k clearance for power-assisted liposuction, in our view further enhancing its attractiveness to aesthetic surgeons.

Apyx Medical (Nasdaq: APYX)
12/31/25-5/29/26

Apyx Medical Performance Chart from 12/31/25-5/29/26

Past performance is no guarantee of future results.

We also think that both the launch and expanded indication for AYON come at a very opportune moment. The rapid adoption of GLP-1 weight loss medications has produced what we think is a temporary headwind as liposuction procedures have been declining. However, the effectiveness of GLP-1 drugs results in very rapid weight loss—and associated skin laxity. In our opinion, this is now spurring demand for comprehensive skin contouring procedures to reduce skin laxity. We see our investment in Apyx as an early-stage opportunity.

LSI Industries (Nasdaq: LYTS) provides lighting and retail display systems. One reason we like the stock is that LSI has differentiated itself from other lighting manufacturers by providing consulting and other services to help customers utilize better lighting and display capabilities to build brand differentiation. These services have found meaningful interest from the petroleum market, convenience stores, and multi-chain retail enterprises.

LSI Industries (Nasdaq: LYTS)
12/31/25-5/29/26

LSI Industries Performance Chart from 12/31/25-5/29/26

Past performance is no guarantee of future results.

LSI recently expanded its display capabilities through the strategic acquisition of Royston Group, which provides a strongly complementary product set in areas such as internal/external signage, metal shelving, and heated display cases, as well as offering a somewhat distinct customer base. In addition to typical acquisition synergy, we see a broad cross-selling opportunity that we expect to unfold over the next several years.

TrueBlue (NYSE: TBI) is a leading provider of staffing, recruitment process outsourcing, and managed services covering employment-related functions. Its suite of services ranges from temporary staffing across numerous industry verticals to higher-end permanent placements services. TrueBlue is in the process of expanding its services into higher-end offerings while at the same time attempting to rationalize a broad branch network for its lower-end staffing business. Compounding these challenges has been an overall slowdown in temporary staffing demand, as well as the potential disintermediating impact of AI.

TrueBlue (NYSE: TBI)
12/31/25-5/29/26

TrueBlue Performance Chart from 12/31/25-5/29/26

Past performance is no guarantee of future results.

However, TrueBlue is also beginning to see the first greens shoots of its branch reorganization efforts just as overall industry demand is just starting to improve—with a positive impact on operating margins. We also think that top industry players like TrueBlue will ultimately use AI to their advantage to become more ingrained with their customers.

Important Disclosure Information

Average Annual Total Returns as of 3/31/2026 (%)

  QTD1 1YR 3YR 5YR 10YR SINCE
INCEPT.
DATE ANNUAL
OPERATING EXPENSES
NET               GROSS
Micro-Cap 9.23 45.42 17.76 7.62 11.53 10.83 12/31/91  1.24  1.26
Russell Microcap
1.49 45.78 16.88 3.13 10.36 N/A N/A  N/A  N/A
Russell 2000
0.89 25.72 13.05 3.77 9.88 9.30 N/A  N/A  N/A
1 Not annualized.

Average Annual Total Returns as of 5/31/2026 (%)

  QTD1 1YR 3YR 5YR 10YR SINCE
INCEPT.
DATE ANNUAL
OPERATING EXPENSES
NET               GROSS
Micro-Cap 15.58 71.87 25.68 10.09 12.94 11.27 12/31/91  1.24  1.26
Russell Microcap
12.39 64.61 22.59 5.51 11.30 N/A N/A  N/A  N/A
Russell 2000
12.21 44.41 18.19 5.75 10.98 9.64 N/A  N/A  N/A
1 Not annualized.

All performance information reflects past performance, is presented on a total return basis, reflects the reinvestment of distributions, and does not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, so that shares may be worth more or less than their original cost when redeemed. Current month-end performance may be higher or lower than performance quoted and may be obtained at www.royceinvest.com. Operating expenses for Royce Micro-Cap Fund reflect the Fund’s total annual operating expenses for the Investment Class as of the Fund’s most current prospectus and include management fees and other expenses.

Mr. Stoeffel’s and Mr. Palen’s thoughts and opinions about the stock market are solely their own, and there can be no assurance about future market movements. No assurance can be given that the past performance trends as outlined above will continue in the future. The performance data and trends outlined in this presentation are presented for illustrative purposes only. Past performance is no guarantee of future results. Historical market trends are not necessarily indicative of future market movements.

Percentage of Fund Holdings As of 3/31/26 (%)

  Micro-Cap

Apyx Medical

0.7

LSI Industries

0.8

TrueBlue

0.3

Company examples are for illustrative purposes only. This does not constitute a recommendation to buy or sell any stock. There can be no assurance that the securities mentioned in this piece will be included in any Fund’s portfolio in the future.

This material is not authorized for distribution unless preceded or accompanied by a current prospectus. Please read the prospectus carefully before investing or sending money. The performance data and trends outlined in this article are presented for illustrative purposes only. Past performance is no guarantee of future results. Historical market trends are not necessarily indicative of future market movements. Investments in securities of micro-cap, small-cap, and/or mid-cap companies may involve considerably more risk than investments in securities of larger-cap companies. (Please see "Primary Risks for Fund Investors" in the prospectus.) Investments in foreign companies may be subject to different risks than investments in securities of U.S. companies, including adverse political, social, economic, or other developments that are unique to a particular country or region. (Please see "Investing in International Securities" in the prospectus.)

Sector weightings are determined using the Global Industry Classification Standard ("GICS"). GICS was developed by, and is the exclusive property of, Standard & Poor's Financial Services LLC ("S&P") and MSCI Inc. ("MSCI"). GICS is the trademark of S&P and MSCI. "Global Industry Classification Standard (GICS)" and "GICS Direct" are service marks of S&P and MSCI.

Frank Russell Company (“Russell”) is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Frank Russell Company. Neither Russell nor its licensors accept any liability for any errors or omissions in the Russell Indexes and / or Russell ratings or underlying data and no party may rely on any Russell Indexes and / or Russell ratings and / or underlying data contained in this communication. No further distribution of Russell Data is permitted without Russell’s express written consent. Russell does not promote, sponsor, or endorse the content of this communication. All indexes referenced are unmanaged, and capitalization weighted. The Russell 2000 Index is an index of domestic small-cap stocks that measures the performance of the 2,000 smallest publicly traded U.S. companies in the Russell 3000 Index. The Russell 1000 Index is an unmanaged, capitalization-weighted index of domestic large-cap stocks. It measures the performance of the 1,000 largest publicly traded U.S. companies in the Russell 3000 Index. The Russell 2000 Value and Growth indexes consist of the respective value and growth stocks within the Russell 2000 as determined by Russell Investments. The Russell Top 50 Index measures the performance of the largest companies in the Russell 3000 Index. It includes approximately 50 of the largest securities based on a combination of their market cap and current index membership and represents approximately 40% of the total market capitalization of the Russell 3000 Index. The performance of an index does not represent exactly any particular investment, as you cannot invest directly in an index.

Share:

Subscribe:

Sign Up

Follow: